A member of a new class of antiretroviral drugs is safe and effective for patients beginning treatment against HIV, according to researchers who have completed a two-year multisite phase III clinical trial comparing it with ...

Medicine & Health - HIV & AIDS

Aug 03, 2009 not rated yet 0